Cypherpunk Technologies Inc.
As of Oct 22, 2026, Cypherpunk Technologies is in Stage 2, the uptrend phase, now in week 7 (since Sep 8, 2026). It closed at $2.98, 27.7% below its 52-week high and above its 200-day average, which is rising.
Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 45 in Asset Management · #1 of 215 in Financials
Is CYPH early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
CYPH among Asset Management1st of 140 by relative strength
All 140 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CYPH | Stage 2 · wk 7 | 99 | −17.5% |
| 2 | AMTD | Stage 2 · wk 1 | 99 | +4011.1% |
| 3 | MGLD | Stage 2 · wk 4 | 94 | +105.2% |
| 4 | AAMI | Stage 2 · wk 41 | 94 | +1.4% |
| 5 | ASST | Stage 2 · wk 7 | 92 | +0.1% |
| 6 | AMG | Stage 2 · wk 21 | 91 | +8.0% |
| 7 | WT | Stage 2 · wk 39 | 91 | −10.6% |
| 8 | VCTR | Stage 2 · wk 39 | 91 | +1.0% |
Cypherpunk Technologies: quick answers
What stage is Cypherpunk Technologies in?
As of Oct 22, 2026, Cypherpunk Technologies (CYPH) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 8, 2026 and is in week 7. What the four stages mean
Is Cypherpunk Technologies in an uptrend?
Yes. Cypherpunk Technologies is in a Stage 2 uptrend. It trades 143.8% above its 200-day average, which is rising.
How far is Cypherpunk Technologies from its 52-week high?
Cypherpunk Technologies closed at $2.98 on Oct 22, 2026, 27.7% below its 52-week high of $4.12. Its 52-week low is $0.41.
How has Cypherpunk Technologies performed over the past year?
As of Oct 22, 2026, Cypherpunk Technologies is up 513.2% over the past year and up 163.7% so far in 2026.
Which sector and industry is Cypherpunk Technologies in?
Cypherpunk Technologies is in the Asset Management industry, part of the Financials sector.
About this companyFinancials· Asset Management
Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.